HomeSUPN • NASDAQ
Supernus Pharmaceuticals Inc
add
$32.96
1.96%
After Hours:(0.00%)0.00
$32.96
Closed: Jun 18, 4:02:29 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 149.82M | 4.30% |
Operating expense | 141.06M | 7.20% |
Net income | -11.83M | -9,637.90% |
Net profit margin | -7.89 | -8,866.67% |
Earnings per share | 0.44 | 84.79% |
EBITDA | 13.39M | -18.87% |
Effective tax rate | -102.83% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 463.59M | 55.71% |
Total assets | 1.35B | 3.31% |
Total liabilities | 316.59M | -15.56% |
Total equity | 1.03B | — |
Shares outstanding | 55.99M | — |
Price to book | 1.76 | — |
Return on assets | -1.29% | — |
Return on capital | -1.64% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -11.83M | -9,637.90% |
Cash from operations | 30.60M | -20.32% |
Cash from investing | 37.32M | 172.29% |
Cash from financing | -21.40M | -1,462.99% |
Net change in cash | 46.52M | 499.18% |
Free cash flow | 22.54M | -42.13% |
Previous close
$32.33
Day range
$32.01 - $33.26
Year range
$25.55 - $40.28
Market cap
1.85B USD
Avg Volume
529.06K
P/E ratio
29.84
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2005
Headquarters
Website
Employees
674
